Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Vets treat Chihuahua with rare dwarfism condition
Pixie was diagnosed with hyposomatotropism.
Pixie weighed just 500g at six months old.

A Chihuahua with a rare dwarfism condition is making good progress after receiving growth hormone treatment at the Royal (Dick) School of Veterinary Studies’ Hospital for Small Animals.

Pixie was referred to the hospital when she was six months old after her veterinary surgeon had become concerned about her growth and development.

When referred to the hospital, she weighed less than 500 grammes. She was uncoordinated, her energy levels were very low, and she had collapsed several times due to low blood sugar despite being regularly fed. Her baby teeth had also still not been replaced with adult teeth.

The veterinary team at the hospital conducted a series of scans and tests, leading to a diagnosis of hyposomatotropism (pituitary dwarfism).

Pixie was prescribed regular injections of progesterone to stimulate the production of growth hormone from her mammary glands to replace the lack of hormones from her underdeveloped pituitary gland.

After a few months of the treatment, Pixie reached a healthy weight and body condition. She was also able to better regulate her glucose levels and gained her adult teeth.

The treatment will need to be continued for the rest of Pixie’s life and, despite now being a healthy weight, she will be smaller than other Chihuahuas.

Alisdair Boag, a senior lecturer at the Royal (Dick) School and an RCVS specialist in small animal medicine, said: “Pixie is a wonderful patient; watching her grow and thrive has been a real pleasure.

“It is so rewarding to see the positive difference we can make for our patients and their owners.”

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster